Search found 6076 matches
- Tue Mar 12, 2024 12:23 am
- Forum: General Discussion
- Topic: Micro & nanoplatics in arterial plaques
- Replies: 0
- Views: 384
Micro & nanoplatics in arterial plaques
A recent report discovered a surprising amount of micro and nanoplastics in bottled water. https://www.npr.org/2024/01/10/1223730333/bottled-water-plastic-microplastic-nanoplastic-study Now we learn that these plastics are not inert and can also be found to accumulate in the vascular system contribu...
- Sun Mar 10, 2024 11:53 pm
- Forum: Diet
- Topic: Neuroprotective effects of berries
- Replies: 0
- Views: 2029
Neuroprotective effects of berries
Neuroprotective effects of berry fruits on neurodegenerative diseases Neural Regen Res. 2014 Aug 15;9(16):1557-66. Recent clinical research has demonstrated that berry fruits can prevent age-related neurodegenerative diseases and improve motor and cognitive functions. The berry fruits are also capa...
- Fri Mar 08, 2024 8:03 pm
- Forum: General Discussion
- Topic: Saccharomyces boulardii probiotic
- Replies: 8
- Views: 982
Re: Saccharomyces boulardii probiotic
This is the Saccharomyces boulardii probiotic I just ordered and received. 200 billion CFU , priced right at $24 - an exceptional value. https://www.amazon.com/dp/B0CLKF5NWP Some of the reviews aren't so good. I bought these to make fermented probiotic apple juice. After 48 hours there is zero ferm...
- Fri Mar 08, 2024 7:00 am
- Forum: General Discussion
- Topic: Saccharomyces boulardii probiotic
- Replies: 8
- Views: 982
Re: Saccharomyces boulardii probiotic
Keep in mind while billions of anything sounds like a lot, the population of bacteria in the gut is in the multiple trillions . Just for clarity, Saccharomyces boulardii is a yeast. The study posted used a S. boulardii supplement with just 1010 CFUs. In addition, I read a paper some time ago that s...
- Thu Mar 07, 2024 9:37 pm
- Forum: Diet
- Topic: Fasting & Neurodegenerative Disease
- Replies: 0
- Views: 713
Fasting & Neurodegenerative Disease
Perspective: The Impact of Fasting and Caloric Restriction on Neurodegenerative Diseases in Humans Adv Nutr. 2024 Mar 1:100197. Neurodegenerative diseases (ND) are characterized by the progressive functional and structural denaturation of neurons in the central and peripheral nervous systems. Despi...
- Thu Mar 07, 2024 9:14 pm
- Forum: General Discussion
- Topic: Saccharomyces boulardii probiotic
- Replies: 8
- Views: 982
- Mon Mar 04, 2024 9:17 am
- Forum: General Discussion
- Topic: RE: CLEMASTINE FUMARATE RESTORES MYELIN IN M.S
- Replies: 7
- Views: 1846
Re: Clemastine Trial Halted Following Increased Disability Accumulation in PPMS!
More info... https://www.neurologylive.com/view/clemastine-arm-trap-ms-trial-halted-following-increased-disability-accumulation-progressive-ms In the trial, investigators halted the clemastine arm because of 3 participants who increased in disability 5-times faster than compared with 18-month “basel...
- Sun Mar 03, 2024 11:39 am
- Forum: General Discussion
- Topic: Coronavirus (COVID-19) Research
- Replies: 185
- Views: 72427
Re: Coronavirus (COVID-19) Research
Study Reveals Side Effects of COVID-19 Vaccines COVID-19 vaccines produce some very serious side effects such as Guillain Barré syndrome, but for the most part these are rare. Terry Graedon - February 29, 2024 https://www.peoplespharmacy.com/articles/study-reveals-side-effects-of-covid-19-vaccines ...
- Sun Feb 25, 2024 4:50 am
- Forum: Drug Pipeline
- Topic: Summary of the pipeline
- Replies: 437
- Views: 220447
Re: AICAR
This is from 2019. What Athletes Should Know About AICAR and Other Prohibited AMP Activated Protein Kinase Activators Education, Spirit of Sport / November 14, 2019 https://www.usada.org/spirit-of-sport/education/aicar-and-other-prohibited-amp-activated-protein-kinase-activators/ In recent years, AI...
- Sun Feb 25, 2024 3:55 am
- Forum: Drug Pipeline
- Topic: Summary of the pipeline
- Replies: 437
- Views: 220447
Frexalimab phase 2 trial
Inhibition of CD40L with Frexalimab in Multiple Sclerosis N Engl J Med. 2024 Feb 15;390(7):589-600. Background : The CD40-CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation a...
- Sat Feb 10, 2024 5:12 am
- Forum: General Discussion
- Topic: The NERVGEN-291 miracle!
- Replies: 10
- Views: 2399
Re: The NERVGEN-291 miracle!
This paper from 2018 focused on MS (EAE). Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis Nature Commun. 2018 Oct 8;9(1):4126. Multiple Sclerosis (MS) is characterized by focal CNS inflammation leading to the death of oligodendrocytes (OLs...
- Fri Feb 09, 2024 4:32 am
- Forum: General Discussion
- Topic: The NERVGEN-291 miracle!
- Replies: 10
- Views: 2399
- Fri Feb 09, 2024 4:02 am
- Forum: General Discussion
- Topic: EBV Vaccine from QIMR Berghofer, Australia
- Replies: 1
- Views: 619
Re: EBV Vaccine from QIMR Berghofer, Australia
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice Nat Commun. 2023 Aug 8;14(1):4371. The recent emergence of a causal link between Epstein-Barr virus (EBV) and multiple sclerosis has generated considerable interest in the development of an e...
- Fri Feb 09, 2024 3:51 am
- Forum: General Discussion
- Topic: EBV Vaccine from QIMR Berghofer, Australia
- Replies: 1
- Views: 619
EBV Vaccine from QIMR Berghofer, Australia
First-Ever Vaccine Candidate Against Epstein-Barr Delivers Promising Results August 9, 2023 by David Nield https://www.sciencealert.com/first-ever-vaccine-candidate-against-epstein-barr-delivers-promising-results Researchers have made a significant breakthrough in the development of the first-ever ...
- Thu Feb 08, 2024 10:33 am
- Forum: General Discussion
- Topic: The NERVGEN-291 miracle!
- Replies: 10
- Views: 2399
Re: The NERVGEN-291 miracle!
Here's an interview with the two founders of NervGen and the CEO. They discuss the background science leading to the development of NVG-291, the design of the current phase 1b-2a trial and plans for a larger phase 2 trial.